Physician profile
Manuj Agarwal
NPI 1316262363
$13,091.76
in general payments reported to CMS, 2019-2025
7 companies · $7,537 in 2025
The $7,537 reported for 2025 was more than what 96% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.49 · 2021: $144 · 2022: $3,802 · 2023: $770 · 2024: $813 · 2025: $7,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,250 · Travel and Lodging: $1,139 · Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,250.00 |
| Travel and Lodging | $1,139.29 |
| Food and Beverage | $731.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $7,639.43 | 2024-2025 | Flexitron Hdr |
| Siemens Medical Solutions USA, INC. | $3,741.33 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $1,150.83 | 2023-2024 | Model 200 Theraseed Palladium-103 In Readylink |
| Bioprotect Medical, INC. | $233.74 | 2024 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $144.24 | 2021 | |
| Teleflex LLC | $96.45 | 2024-2025 | Barrigel |
| Isoray, INC | $85.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuj Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.